Mito-fisetin mF7

Overview

Mito-fisetin mF7 is a lipophilic derivative of Fisetin ( HY-N0182 ). Mito-fisetin mF7 interacts with AKT and Bcl-2 , limiting their stability and functionality. Mito-fisetin mF7 stimulates impairs mitochondrial function and reduces metabolic activity of cancer cells. Mito-fisetin mF7 can be used for the research of ER-positive breast cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Others | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Akt | Products > Signaling Pathways > Bcl-2 Family | Products > Signaling Pathways > Drug Derivative

Product Information

• Catalog No.: HY-185559
• CAS No.: 3106880-06-9
• Molecular Formula: C52H42IO7P
• Molecular Weight: 936.76
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source